Alexander J Makowski, PhD; Chief Scientist at Sage Analytics writes for Terpenes and Testing Magazine about the challenges and opportunities ahead as states race towards recreational legalization while cannabis is still federally illegal.

Amidst the chaos and uncertainty of evolving and expanding cannabis regulations, one thing alone is clear: all responsible parties desire legislation that provides the highest level of patient safety. At first glance, this may make the disagreements, lobbying, and even protesting seem less meaningful; however, the devil is in the details. Despite the unanimous consensus about the overarching goal of cannabis regulation, the inevitable dispute about current legislation arises as concerned parties disagree on the best methods and execution strategies in order to achieve this lofty goal.

Full article below.